Reports Q4 revenue $707.1M, consensus $688.7M. Eric Evans, Chief Executive Officer, stated, "With revenue growth of nearly 16% in the fourth quarter, we are reporting growth consistent with our expectations and reflecting the positive trajectory that we have experienced all year. Our teams remain focused on providing the highest clinical quality product to our patients and physicians as we continue to make investments in our core capabilities including physician recruitment, high-acuity service line development, and effectively managing the macro-economic environment with regards to inflationary pressure on labor and our supply chain while still achieving full year margin improvement. On a same-facility basis, net revenue grew nearly 11% in the quarter and 8% for the year, giving us significant momentum as we enter 2023. When coupled with our consistent and accretive deployment of capital, which totaled nearly $250 million in 2022, our growth trajectory is strong and gives us high confidence in in our 2023 guidance."
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on SGRY:
- Surgery Partners, Inc. Announces Fourth Quarter and Full Year 2022 Results; Sets 2023 Guidance
- Surgery Partners, Inc. Announces Fourth Quarter 2022 Earnings Release Date and Conference Call Details
- Surgery Partners reaffirms 2022 revenue view $2.5B-$2.55B, consensus $2.52B
- Surgery Partners, Inc. Reaffirms 2022 Full Year Guidance
- Surgery Partners, Inc. To Present At Upcoming Investor Conference